Dobromir Dobrev
0000-0002-4612-117X
202 papers found
Refreshing results…
Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart
One for all and all for one? The dilemma of optimal management of atrial fibrillation with cardiac co-morbidities
The role of amiodarone in contemporary management of complex cardiac arrhythmias
Atrial fibrillation in a dish: insights into atrial arrhythmogenesis from induced pluripotent stem cell-derived cardiomyocytes
Prognostic value of biomarkers of impaired metabolism in heart failure patients with reduced ejection fraction
Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction
Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs
Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator
Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring
Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter?
Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants
Atrial Ca2+/calmodulin-dependent protein kinase II: A druggable master switch of atrial fibrillation-associated atrial remodeling?
Role of inflammatory signaling in atrial fibrillation
Computational modeling: What does it tell us about atrial fibrillation therapy?
Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation
Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?
Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
DPP10 is a new regulator of Nav1.5 channels in human heart
Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
Missing publications? Search for publications with a matching author name.